Jet.AI and flyExclusive Remain Committed to Transaction – Closing Expected in the First Quarter of 2026

(NASDAQ:JTAI),(NYSE:FLYX), Las Vegas, NV, Jan. 14, 2026 (GLOBE NEWSWIRE) — Jet.AI Inc. (“Jet.AI” or the “Company”) (Nasdaq: JTAI), an emerging provider of high-performance GPU infrastructure and AI cloud services, today announced that the parties have extended the outside date of the merger agreement between flyExclusive, Inc. (NYSE American: FLYX) (“flyExclusive”) and Jet.AI to April 30th, […]

SemiCab Exits 2025 With Record $10 Million Annualized Revenue Run Rate

(NASDAQ:RIME), Company Achieves Record ARR in December, Representing a 300% Increase Over the Past 12 Months Fort Lauderdale, FL, Jan. 14, 2026 (GLOBE NEWSWIRE) — Algorhythm Holdings, Inc. (“Algorhythm”) (NASDAQ: RIME) – a leading AI technology company, announced today that achieved an annualized revenue run rate (“ARR”) of $9.7 million during December 2025, representing a

Senti Biosciences Participates in Virtual Investor CEO Connect Segment to Discuss the Company’s Groundbreaking AML Data at the American Society of Hematology Annual Meeting and Recently Granted RMAT Designation

(NASDAQ:SNTI), Access the segment here SOUTH SAN FRANCISCO, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that it participated in a Virtual Investor CEO Connect Segment. As part of the segment,

Navient to announce fourth quarter and year-end 2025 results, host earnings webcast Jan. 28

(NASDAQ:NAVI), HERNDON, Va., Jan. 14, 2026 (GLOBE NEWSWIRE) — Navient (Nasdaq: NAVI) will host an audio webcast to review its 2025 fourth quarter and year-end financial results on Wednesday, Jan. 28, 2026, at 8:00 a.m. Eastern Time. The webcast will be available on Navient.com/investors; a replay of the webcast will be available on the site.

Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting

(NASDAQ:MYNZ), BERKELEY, Calif. and , Jan. 14, 2026 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, is excited to announce its participation in the upcoming American Association for Cancer Research (AACR) 2026 Annual Meeting. This prestigious conference will be held April 17 to

SemiCab Exits 2025 With Record $10 Million Annualized Revenue Run Rate

SemiCab Exits 2025 With Record $10 Million Annualized Revenue Run Rate GlobeNewswire January 14, 2026 Company Achieves Record ARR in December, Representing a 300% Increase Over the Past 12 Months Fort Lauderdale, FL, Jan. 14, 2026 (GLOBE NEWSWIRE) — Algorhythm Holdings, Inc. (“Algorhythm”) (NASDAQ: RIME) – a leading AI technology company, announced today that achieved

Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting

Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting First data on blood-based mRNA signature for pancreatic ductal adenocarcinoma (PDAC) detection and intraductal papillary mucinous neoplasms (IPMN) differentiation to be presented in San Diego GlobeNewswire January 14, 2026 BERKELEY, Calif. and , Jan. 14, 2026 (GLOBE NEWSWIRE) — Mainz

Jet.AI and flyExclusive Remain Committed to Transaction – Closing Expected in the First Quarter of 2026

Jet.AI and flyExclusive Remain Committed to Transaction – Closing Expected in the First Quarter of 2026 GlobeNewswire January 14, 2026 Las Vegas, NV, Jan. 14, 2026 (GLOBE NEWSWIRE) — Jet.AI Inc. (“Jet.AI” or the “Company”) (Nasdaq: JTAI), an emerging provider of high-performance GPU infrastructure and AI cloud services, today announced that the parties have extended

Senti Biosciences Participates in Virtual Investor CEO Connect Segment to Discuss the Company’s Groundbreaking AML Data at the American Society of Hematology Annual Meeting and Recently Granted RMAT Designation

Senti Biosciences Participates in Virtual Investor CEO Connect Segment to Discuss the Company's Groundbreaking AML Data at the American Society of Hematology Annual Meeting and Recently Granted RMAT Designation GlobeNewswire January 14, 2026 Access the segment here SOUTH SAN FRANCISCO, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a

Navient to announce fourth quarter and year-end 2025 results, host earnings webcast Jan. 28

Navient to announce fourth quarter and year-end 2025 results, host earnings webcast Jan. 28 GlobeNewswire January 14, 2026 HERNDON, Va., Jan. 14, 2026 (GLOBE NEWSWIRE) — Navient (Nasdaq: NAVI) will host an audio webcast to review its 2025 fourth quarter and year-end financial results on Wednesday, Jan. 28, 2026, at 8:00 a.m. Eastern Time. The

Scroll to Top